Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALTWATER: Tolvaptan Safety Extension in Hyponatremia
NCT02449044Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- May 2004
- Primary completion
- Oct 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tolvaptan in hyponatremia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started May 2004; status: completed.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT02449044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449044.